Lindsay Rosenwald

Chairman, President, Chief Executive Officer, Fortress Biotech

Dr. Rosenwald has served as Chairman, President & CEO of Fortress Biotech since December 2013 and has served as a member of the Fortress Board of Directors since October 2009. Since 2009, Dr. Rosenwald has served as Co-Portfolio Manager and Partner of Opus Point Partners, LLC (‘Opus’), an asset management firm in the life sciences industry. Prior to that, from 1991 to 2008, he served as the Chairman of Paramount BioCapital, Inc. Over the last 23 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and been instrumental in the founding and recapitalization of numerous public and private biotechnology and life sciences companies. Dr. Rosenwald received his B.S. in Finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.

Claude Maraoui

President & Chief Executive Officer, Journey Medical Corporation

Claude has more than 30 years of experience in commercializing some of the most successful dermatology products in the world. He served as Vice President of Dermatology Sales at Medicis Pharmaceutical Corporation and has held various leadership positions in marketing and sales for therapeutic and aesthetic dermatology. He has executed more than 50 product launches during his career. In 2012, Valeant Pharmaceuticals International Inc., acquired Medicis for approximately $2.6B. Claude received his B.S. in Business and Marketing from Rutgers University.

Robert Nevin

Chief Commercial Officer, Journey Medical Corporation

Robert has more than 24 years of experience in pharmaceutical, lab and medical management and oversees all sales, trade and managed care functions at Journey. He came to Journey from The Dermatology Alliance, where he served as Managing Partner for one of the nation’s largest independent physician associations in the specialty of dermatology. Robert received his B.S. in Business Administration and Finance from Seton Hall University.

Andrew Zwible

Vice President Operations, Journey Medical Corporation

Andrew has more than 10 years of experience in dermatology pharmaceuticals, working for Medicis and Valeant as a forecasting and analytics expert. At Medicis he assisted with the $455MM acquisition of Graceway Pharmaceuticals LLC and the sell-side $2.6B acquisition of Medicis. He has previous experience in investment banking and financial analysis. Andrew received his B.S. in Biomedical/Medical Engineering from Johns Hopkins University, his M.S. in Health Care Administration/Management from Arizona State University and his M.B.A. in Finance from Arizona State University.

Ernest Galvan

Vice President Marketing & Strategic Planning, Journey Medical Corporation

Ernest has more than 26 years of experience in the dermatology pharmaceutical industry. With over 23 years in brand management and development, he has translated concepts into powerful marketing and brand solutions for a variety of dermatologic lines. Prior to Journey Medical, his experience includes Bristol Myers Squibb, Medicis, Ranbaxy, and Sun Dermatology. Ernest received his B.B.A. in Marketing from Stephen F. Austin State University and his M.B.A. in Marketing from La Salle University.

Marisol Graichen

National Sales Director, Journey Medical Corporation

Marisol has over 19 years of achieving business objectives and 14 years in business leadership. Her experience spans across various markets including, therapeutic, aesthetic, medical device, and cosmeceutical. Prior to joining Journey, Marisol served in a leadership role at PharmaDerm a subsidiary of Sandoz/Novartis for 5 years. Marisol established her Dermatology career at Medicis in 2001 where she served the company in increasing leadership roles for 14 years. Marisol holds a B.A. in Communications from St. Mary’s University and received her M.B.A. in Business Management from Our Lady of the Lake University. Marisol is fluent in Spanish.